$1.400
-0.024 (-1.75%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Innate Pharma SA (IPHA) Moving Averages Convergence Divergence (MACD) indicator is -0.07, suggesting IPHA is Strong sell.
Innate Pharma SA (IPHA) 20-Day simple moving average is 1.48, while Innate Pharma SA (IPHA) share price is $—, making it Sell.
Innate Pharma SA (IPHA) 60-Day simple moving average is 1.78, while Innate Pharma SA (IPHA) share price is $—, making it Sell.
Technical Analysis for IPHA
AI Technical IPHAAs of 2026-11-03, the technical board for Innate Pharma SA (IPHA) reads strong sell: 1 indicators are flashing buy, 9 are indicating sell, and 3 are neutral. Price at $1.40 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 40.185, MACD stands at -0.0739 (Sell), Stochastic %K stands at 23.214, Stochastic %D stands at 17.643 and CCI stands at -113.145 (Buy).
IPHA trades below the 60-day SMA (1.78) and below the 200-day SMA (1.71). Immediate resistance sits at Classic R1 1.57, then R2 1.70. Support sits at Classic S1 1.32, then S2 1.20.
Innate Pharma SA (IPHA) Support & Resistance Level
Innate Pharma SA (IPHA) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 40.185 |
| STOCHk_14_3_3 | 23.214 |
| STOCHd_14_3_3 | 17.643 |
| CCI_20 | -113.145 |
| AO_5_34 | -0.150 |
| MOM_10 | -0.100 |
| MACD_12_26_9 | -0.074 |
Innate Pharma SA (IPHA) Relative Strength Index (RSI_14) is 40.185, creating a Neutral signal.
Innate Pharma SA (IPHA) Stochastic %K is 23.214, creating a Neutral signal.
Innate Pharma SA (IPHA) Stochastic %D is 17.643, creating a Buy signal.
Innate Pharma SA (IPHA) CCI_20 is -113.145, creating a Buy signal.
Innate Pharma SA (IPHA) Awesome Oscillator (AO) is -0.150, creating a Sell signal.
Innate Pharma SA (IPHA) Momentum (MOM) is -0.100, creating a Sell signal.
Innate Pharma SA (IPHA) Moving Average Convergence Divergence (MACD) is -0.074, creating a Sell signal.
Innate Pharma SA (IPHA) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.403 | Sell |
| MA_10 | 1.448 | Sell |
| MA_20 | 1.475 | Sell |
| MA_60 | 1.785 | Sell |
| MA_200 | 1.706 | Sell |
| MA_250 | 1.731 | Sell |
Innate Pharma SA (IPHA) 5-Day simple moving average is 1.403, while Innate Pharma SA (IPHA) share price is $, making it a Sell.
Innate Pharma SA (IPHA) 10-Day simple moving average is 1.448, while Innate Pharma SA (IPHA) share price is $, making it a Sell.
Innate Pharma SA (IPHA) 20-Day simple moving average is 1.475, while Innate Pharma SA (IPHA) share price is $, making it a Sell.
Innate Pharma SA (IPHA) 60-Day simple moving average is 1.785, while Innate Pharma SA (IPHA) share price is $, making it a Sell.
Innate Pharma SA (IPHA) 200-Day simple moving average is 1.706, while Innate Pharma SA (IPHA) share price is $, making it a Sell.
Innate Pharma SA (IPHA) 250-Day simple moving average is 1.731, while Innate Pharma SA (IPHA) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.